Savient Pharmaceuticals Inc (SVNT) Return on Assets ROA from the third quarter of 2013 to third quarter of 2012 and for the year 2013, Average High and Low, Fundamental Ratios from Sep 30 2013 to Sep 30 2012 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Savient Pharmaceuticals Inc  (SVNT)


Savient Pharmaceuticals Inc's ROA from the third quarter of 2013 to the third quarter of 2012 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Savient Pharmaceuticals Inc's ROA in the third quarter of 2013?
Savient Pharmaceuticals Inc recorded a cumulative net loss of $-98 million during 12 months ending in the third quarter of 2013, resulting in a negative return on assets (ROA) of -114.28%.

However, within the Healthcare sector 429 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2013 from 4320 to 4538.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter		 (Dec 31 2012)
IV. Quarter		 (Sep 30 2012)
III. Quarter
Y / Y Total Assets Change -61.88 % -57.77 % -41 % -39.52 % -25.26 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -98 -118 -109 -118 -90
Return On Assets (TTM) -114.28 % -107.78 % -80.8 % -78.48 % -53.03 %
SVNT's Total Ranking # 4538 # 4320 # 4316 # #
Total Assets (TTM) in million 57 74 94 119 149
Seq. Total Assets Change -22.97 % -21.92 % -20.75 % -20.02 % -14.67 %
Seq. Net Income Change - - - - -

SVNT's 5 Years Annual ROA >> Back to SVNT Management Effectiveness >> Compare SVNT ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 55
Sector # 430
Overall # 3639

Return On Assets Statistics
High Average Low
-33.92 %
-79.57 %
-115.99 %
(Sep 30 2011)   (Sep 30 2013)





Financial Statements
Savient Pharmaceuticals Inc's Assets $ 57 million SVNT's Balance sheet
Savient Pharmaceuticals Inc's Income $ -20 million Quarterly SVNT's Income Statement
SVNT's Income by Division See SVNT's Income by Division



Annual Return On Assets (Dec 31 2012)
FY 2012		 (Dec 31 2011)
FY 2011		 (Dec 31 2008)
FY 2010
FY
FY
Y / Y Total Assets Change -39.52 % 69.47 % - - -
Total Assets in million 119 197 116 0 0
Y / Y Net Income Change - - - - -
Net Income in million -118 -102 -84 0 0
Annual Return On Assets -99.25 % -51.76 % -72.37 % - -

SVNT's 5 Years Annual ROA >> Back to SVNT Management Effectiveness >> Compare SVNT ROA to its Competitors



More Return On Assets Ratios
SVNT's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SVNT's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SVNT's Competitors
Subscribers only: Roa for Savient Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Assets for SVNT's Customers

You may also want to know
SVNT's Roi SVNT's Inventory Turnover Ratio SVNT's Growth Rates SVNT's Dividend Comparisons
SVNT's Profitability Ratios SVNT's Asset Turnover Ratio SVNT's Dividend Growth
SVNT's Roe SVNT's Valuation Ratios SVNT's Financial Strength Ratios SVNT's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2013, within Healthcare Sector ROA

Date modified: 2026-09-02T17:38:16+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.